The high potency APIs market projected to grow from USD 24.15 billion in 2022 to USD 49.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9% during the forecast period (2023 - 2032).
The High Potency Active Pharmaceutical Ingredients (HPAPI) market is experiencing significant growth, driven by the rising demand for targeted therapies and the increasing prevalence...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian